There are three medications approved by the FDA for the treatment of OUD: buprenorphine; methadone; and naltrexone. All three of these treatments have been demonstrated to be safe and effective. The FDA is working to identify treatment needs, expand access to treatment of existing MOUD, and promote development of new options for evidence-based treatment for OUD.
Notice:
The National Institute of Corrections is currently assessing its website and materials in accordance with recent Executive Orders and related guidance. During this review, some of NIC’s webpages and publications may be temporarily unavailable. Please revisit this web page for updates.
Food and Drug Administration (FDA)
Notice about external resources
These links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by the National Institute of Corrections (NIC) of any of the products, services or opinions of the corporation or organization or individual. NIC bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.
- Created:Updated: